“Slezavit As a Component of Neuroprotective Therapy for Primary Open-Angle Glaucoma”. Eurasian Medical Research Periodical 9 (June 18, 2022): 93–95. Accessed April 25, 2026. https://geniusjournals.org/index.php/emrp/article/view/1726.